Drug Discovery Fundamentals: From Target Selection to IND Application

The journey of bringing a life-saving medication to market begins long before clinical trials. Understanding how researchers identify disease targets and develop safe, effective therapeutic compounds is essential for anyone entering the pharmaceutical and biotechnology sectors. This text-based course guides you through the entire preclinical drug discovery pipeline. You will learn how molecular targets are selected, how lead compounds are optimized, and how modern tools are transforming early-stage development, culminating in the preparation of an Investigational New Drug (IND) application. What you'll learn: - Understand the fundamental stages of the drug discovery pipeline from initial concept to preclinical testing. - Identify and validate biological drug targets associated with specific diseases. - Apply principles of lead optimization to improve compound efficacy, safety, and drug-like properties. - Explore modern computational screening methods and machine learning applications in early-stage discovery. - Evaluate pharmacokinetic properties, including absorption, distribution, metabolism, and excretion (ADME). - Navigate the regulatory requirements and documentation needed for filing an Investigational New Drug (IND) application. The course begins with foundational concepts in biochemistry and pharmacology, then systematically walks you through screening methodologies, lead optimization, and preclinical safety testing before concluding with regulatory submission frameworks. It is designed specifically for beginners, aspiring pharmaceutical scientists, biotech professionals, and students looking for a comprehensive introduction to drug development with no prior industry experience required. Start reading today to build a strong foundation in the science and strategy of modern drug discovery.